Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes - Concepedia

Concepedia

Publication | Open Access

Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes

DOI Full Paper Access

23

Citations

23

References

2016

Year

Kyle Baron, Sreeraj Macha, Uli C. Broedl, Valerie Nock, Silke Retlich, Matthew Riggs

Diabetes Therapy

Abstract

Boehringer Ingelheim.

References

	Year	Citations

Page 1